Standardized End Point Definitions for Coronary Intervention Trials

Héctor M. García‐García, Eugène McFadden, Andrew Farb, Roxana Mehran, Gregg W. Stone, John A. Spertus, Yoshinobu Onuma, Marie‐Angèle Morel, Gerrit‐Anne van Es, Bram Zuckerman,

European Heart Journal · 2018 · 311 citations · 23 references

DOIFull text

Open access

Concepts

TL;DR

ARC‑2 is a collaboration among academic research groups, device manufacturers, and regulators from the US, Europe, and Asia. The ARC‑2 initiative revisited and updated coronary device trial endpoint definitions to accommodate complex lesions, novel devices, and patient‑related outcomes, aiming to standardize these endpoints across studies. Through a series of in‑person meetings, stakeholders reviewed device and trial evolution and proposed updated definitions and patient‑outcome recommendations. Stakeholders endorse the consensus endpoint definitions, which are advocated for use in trials and will improve outcome interpretation and cross‑study comparison to evaluate device safety and efficacy.

Abstract

The Academic Research Consortium (ARC)-2 initiative revisited the clinical and angiographic end point definitions in coronary device trials, proposed in 2007, to make them more suitable for use in clinical trials that include increasingly complex lesion and patient populations and incorporate novel devices such as bioresorbable vascular scaffolds. In addition, recommendations for the incorporation of patient-related outcomes in clinical trials are proposed. Academic Research Consortium-2 is a collaborative effort between academic research organizations in the United States and Europe, device manufacturers, and European, US, and Asian regulatory bodies. Several in-person meetings were held to discuss the changes that have occurred in the device landscape and in clinical trials and regulatory pathways in the last decade. The consensus-based end point definitions in this document are endorsed by the stakeholders of this document and strongly advocated for clinical trial purposes. This Academic Research Consortium-2 document provides further standardization of end point definitions for coronary device trials, incorporating advances in technology and knowledge. Their use will aid interpretation of trial outcomes and comparison among studies, thus facilitating the evaluation of the safety and effectiveness of these devices.

References

23